the Effect of Virtual Reality Exercise on Selected Electrolytes Levels in Intradialytic Patients (VRE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: sarah mohamed, master
- Phone Number: 01149967455
- Email: sarahalsyed88@gmail.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients are diagnosed with end stage renal disease on regular dialysis.
- Their ages will be arranged from 20-40 years old.
- All patients are under medical control.
- Patients on regular dialysis more than 3 months.
Exclusion Criteria:
- Visual impairment.
- Severe cognitive impairment.
- Recent major surgery.
- Patients with sever musculoskeletal problems.
- Severe cardiovascular disease limiting exercise.
- Patients with Hemoglobin drop less than 9 g/dl
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Exercise
Twenty patients will receive virtual reality exercise during dialysis sessions three times per weeks for 3 months (30 minutes of guided VR exercise).
|
the patients will receive 30 minutes virtual reality exercise; (5 minutes warm Up stretching exercise - 20 minutes cycling exercise -5 minutes cool down stretching exercise) plus standard care
the patients will receive standard care in the form of medical care
|
|
Active Comparator: standard care
Twenty patients will receive standard care during dialysis sessions three times per weeks for 3 months.
|
the patients will receive standard care in the form of medical care
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum Electrolyte Levels
Time Frame: up to three months
|
Measurements the level of sodium, potassium, calcium and phosphorus by venous blood sample. the normal value for Sodium: 135-145 mEq/L ,Potassium: 3.5-5.0 mEq/L, Calcium: 8.5-10.2 mg/dL, and Phosphorus: 2.5-4.5 mg/dL |
up to three months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood pressure
Time Frame: up to three months
|
A sphygmomanometer will be used to assess blood pressure with normal range 120/80
|
up to three months
|
|
oxygen saturation levels
Time Frame: up to three months
|
A pulse oximeter will be used to assess oxygen saturation level.
95-100% considered normal for healthy individuals
|
up to three months
|
|
functional exercise capacity
Time Frame: up to three months
|
6-Minute Walk Test will be used to assess functional exercises capacity
|
up to three months
|
|
exercise intensity
Time Frame: up to three months
|
The Rated Perceived Exertion (RPE) Scale will be used to assess exercise intensity.
it is a subjective 6-20 scale measuring exercise intensity, where 6 is no effort (rest) and 20 is maximum effort.
|
up to three months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Pathologic Processes
- Male Urogenital Diseases
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Chronic Disease
- Disease Attributes
- Renal Insufficiency
- Pathological Conditions, Signs and Symptoms
- Renal Insufficiency, Chronic
- Health Services Administration
- Health Care Quality, Access, and Evaluation
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Quality of Health Care
- Quality Indicators, Health Care
- Exercise
- Standard of Care
- Exergaming
Other Study ID Numbers
Other Study ID Numbers
- P.T.REC/012/005982
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.